Research on Improving the Matching Efficiency between Cancer Patients and Clinical Trials Based on Machine Learning Algorithms

Authors

  • Xiangtian Hui School of Professional Studies, New York University, New York, NY, 10012, USA Author

DOI:

https://doi.org/10.71222/wx5qfc50

Keywords:

cancer patient matching, clinical trials, machine learning, intelligent matching, structured data integration, natural language processing

Abstract

Clinical trials offer critical opportunities for cancer patients to access novel treatments. However, the current trial matching process is often time-consuming, labor-intensive, and limited by fragmented data and manual screening. This study explores the application of machine learning algorithms to optimize the matching of cancer patients to clinical trials. By constructing structured representations of both patient profiles and trial eligibility criteria, and applying a combination of classification and similarity models, the system efficiently estimates match probabilities. Supplemented by natural language processing, feature extraction, and physician feedback mechanisms, the approach integrates automated recommendations with expert validation in a "model-assisted, human-in-the-loop" workflow. Case analyses demonstrate that this framework achieves high accuracy and significantly improves matching speed, providing effective support for personalized oncology care.

References

1. M. Mirandola, et al., "Cancer patients' attitudes towards the anti-COVID-19 vaccine: A collective case study," Rev. Recent Clin. Trials, vol. 19, no. 1, pp. 62–69, 2024, doi: 10.2174/0115748871258981231024103349.

2. D. Alsadius, S. Sánchez-Gambetta, and M. Simmons, "Where innovation and patients meet to improve cancer care," 2024.

3. T. Fehm, et al., "Efficacy of lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells—the DETECT III clinical trial," Clin. Chem., vol. 70, no. 1, pp. 307–318, 2024, doi: 10.1093/clinchem/hvad144.

4. K. H. El-Shakankery, et al., "Ethnicity and socioeconomic disparities in clinical trial participation for ovarian cancer: A retro-spective observational study in London," Cancers (Basel), vol. 16, no. 21, Art. no. 3590, 2024, doi: 10.3390/cancers16213590.

5. A. J. B. Smith, et al., "Disparities in clinical trial participation in ovarian cancer: A real-world analysis," Gynecol. Oncol., vol. 175, pp. 25–31, 2023, doi: 10.1016/j.ygyno.2023.05.066.

Downloads

Published

25 June 2025

Issue

Section

Article

How to Cite

[1]
X. Hui , Tran., “Research on Improving the Matching Efficiency between Cancer Patients and Clinical Trials Based on Machine Learning Algorithms”, J. Med. Life Sci., vol. 1, no. 3, pp. 74–80, Jun. 2025, doi: 10.71222/wx5qfc50.